IBDEI111 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17423,2)
 ;;=^331920
 ;;^UTILITY(U,$J,358.3,17424,0)
 ;;=F60.3^^73^839^3
 ;;^UTILITY(U,$J,358.3,17424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17424,1,3,0)
 ;;=3^Borderline personality disorder
 ;;^UTILITY(U,$J,358.3,17424,1,4,0)
 ;;=4^F60.3
 ;;^UTILITY(U,$J,358.3,17424,2)
 ;;=^331921
 ;;^UTILITY(U,$J,358.3,17425,0)
 ;;=F34.0^^73^839^4
 ;;^UTILITY(U,$J,358.3,17425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17425,1,3,0)
 ;;=3^Cyclothymic disorder
 ;;^UTILITY(U,$J,358.3,17425,1,4,0)
 ;;=4^F34.0
 ;;^UTILITY(U,$J,358.3,17425,2)
 ;;=^5003538
 ;;^UTILITY(U,$J,358.3,17426,0)
 ;;=F60.7^^73^839^5
 ;;^UTILITY(U,$J,358.3,17426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17426,1,3,0)
 ;;=3^Dependent personality disorder
 ;;^UTILITY(U,$J,358.3,17426,1,4,0)
 ;;=4^F60.7
 ;;^UTILITY(U,$J,358.3,17426,2)
 ;;=^5003637
 ;;^UTILITY(U,$J,358.3,17427,0)
 ;;=F60.4^^73^839^6
 ;;^UTILITY(U,$J,358.3,17427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17427,1,3,0)
 ;;=3^Histrionic personality disorder
 ;;^UTILITY(U,$J,358.3,17427,1,4,0)
 ;;=4^F60.4
 ;;^UTILITY(U,$J,358.3,17427,2)
 ;;=^5003636
 ;;^UTILITY(U,$J,358.3,17428,0)
 ;;=F60.81^^73^839^7
 ;;^UTILITY(U,$J,358.3,17428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17428,1,3,0)
 ;;=3^Narcissistic personality disorder
 ;;^UTILITY(U,$J,358.3,17428,1,4,0)
 ;;=4^F60.81
 ;;^UTILITY(U,$J,358.3,17428,2)
 ;;=^331919
 ;;^UTILITY(U,$J,358.3,17429,0)
 ;;=F60.5^^73^839^8
 ;;^UTILITY(U,$J,358.3,17429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17429,1,3,0)
 ;;=3^Obsessive-compulsive personality disorder
 ;;^UTILITY(U,$J,358.3,17429,1,4,0)
 ;;=4^F60.5
 ;;^UTILITY(U,$J,358.3,17429,2)
 ;;=^331918
 ;;^UTILITY(U,$J,358.3,17430,0)
 ;;=F60.0^^73^839^9
 ;;^UTILITY(U,$J,358.3,17430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17430,1,3,0)
 ;;=3^Paranoid personality disorder
 ;;^UTILITY(U,$J,358.3,17430,1,4,0)
 ;;=4^F60.0
 ;;^UTILITY(U,$J,358.3,17430,2)
 ;;=^5003635
 ;;^UTILITY(U,$J,358.3,17431,0)
 ;;=F60.89^^73^839^10
 ;;^UTILITY(U,$J,358.3,17431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17431,1,3,0)
 ;;=3^Personality disorders, spec, other
 ;;^UTILITY(U,$J,358.3,17431,1,4,0)
 ;;=4^F60.89
 ;;^UTILITY(U,$J,358.3,17431,2)
 ;;=^5003638
 ;;^UTILITY(U,$J,358.3,17432,0)
 ;;=F60.1^^73^839^11
 ;;^UTILITY(U,$J,358.3,17432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17432,1,3,0)
 ;;=3^Schizoid personality disorder
 ;;^UTILITY(U,$J,358.3,17432,1,4,0)
 ;;=4^F60.1
 ;;^UTILITY(U,$J,358.3,17432,2)
 ;;=^108271
 ;;^UTILITY(U,$J,358.3,17433,0)
 ;;=F21.^^73^839^12
 ;;^UTILITY(U,$J,358.3,17433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17433,1,3,0)
 ;;=3^Schizotypal disorder
 ;;^UTILITY(U,$J,358.3,17433,1,4,0)
 ;;=4^F21.
 ;;^UTILITY(U,$J,358.3,17433,2)
 ;;=^5003477
 ;;^UTILITY(U,$J,358.3,17434,0)
 ;;=M54.10^^73^840^3
 ;;^UTILITY(U,$J,358.3,17434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17434,1,3,0)
 ;;=3^Radiculopathy, site unspec
 ;;^UTILITY(U,$J,358.3,17434,1,4,0)
 ;;=4^M54.10
 ;;^UTILITY(U,$J,358.3,17434,2)
 ;;=^5012295
 ;;^UTILITY(U,$J,358.3,17435,0)
 ;;=R21.^^73^840^5
 ;;^UTILITY(U,$J,358.3,17435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17435,1,3,0)
 ;;=3^Rash & other nonspec skin eruption
 ;;^UTILITY(U,$J,358.3,17435,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,17435,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,17436,0)
 ;;=M06.9^^73^840^6
 ;;^UTILITY(U,$J,358.3,17436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17436,1,3,0)
 ;;=3^Rheumatoid arthritis, unspec
 ;;^UTILITY(U,$J,358.3,17436,1,4,0)
 ;;=4^M06.9
 ;;^UTILITY(U,$J,358.3,17436,2)
 ;;=^5010145
 ;;^UTILITY(U,$J,358.3,17437,0)
 ;;=J31.0^^73^840^7
